To study safety and efficacy of Autologous skeletal myoblast derived cell sheet in patients with chronic ischemic heart disease and Heart-failure
Latest Information Update: 05 Apr 2021
Price :
$35 *
At a glance
- Drugs Autologous skeletal myoblast derived cell sheet-Terumo (Primary)
- Indications Heart failure; Ischaemic heart disorders
- Focus Therapeutic Use
- 05 Apr 2021 New trial record